Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-05-01 10:37 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
+27,778 vol |
2,331,414 | |
Filed 2023-05-01 10:36 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
2,303,636 | ||
Filed 2023-05-01 10:34 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-27,778 vol |
0 | |
Filed 2022-05-02 14:00 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$15,000
+27,778 vol $0.54 each |
27,778 | |
Filed 2022-05-02 13:02 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
Filed 2022-05-02 13:01 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$8,100
+15,000 vol $0.54 each |
15,000 | |
Filed 2022-05-02 13:01 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$8,100
+15,000 vol $0.54 each |
||
Filed 2022-05-02 13:01 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-02 13:00 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
150,000 | |
Filed 2022-05-02 13:00 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-07-14 08:01 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+22,500 vol |
22,500 | |
Filed 2020-07-14 08:00 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-07-14 07:59 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
16 - Acquisition or disposition under a prospectus exemption
|
+$15,000 vol |
$15,000 | |
Filed 2020-07-14 07:59 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-07-02 13:34 Tx date 2020-06-30 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
Filed 2020-07-02 13:33 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-02-21 10:37 Tx date 2020-02-19 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,020
+2,000 vol $0.51 each |
2,303,636 | |
Filed 2020-02-21 10:36 Tx date 2020-02-19 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,080
+8,000 vol $0.51 each |
2,301,636 | |
Filed 2020-02-21 10:35 Tx date 2020-02-19 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,800
+10,000 vol $0.48 each |
2,293,636 | |
Filed 2019-01-04 Tx date 2018-12-27 |
$
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
2,283,636 |